LITTLE FALLS, N.J., Nov. 5 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN), through its Crosstex subsidiary, reports significant interest from schools for its hand sanitization and surface disinfectant products in light of increased reported incidence of MRSA (Methicillin-resistant Staphylococcus aureus) skin infections.
According to R. Scott Jones, Cantel Medical's President & CEO, "We are in contact with numerous school officials helping them respond to the growing threat of MRSA and the need to address concerns. They recognize the need for preventative measures against the spread of MRSA and other infectious bacteria and viruses. While school officials recognize that thorough hand washing remains the most effective means of inhibiting spread of germs, studies show that less than half of middle and high school students wash their hands for greater than five seconds. Waterless alcohol-based hand sanitizers, such as Crosstex's SaniTyze(TM) brand, are recommended by the Center for Disease Control (CDC) as an effective method of hand hygiene."
Jay McCann, a Board Member of the Caldwell/West Caldwell, NJ school district says, "MRSA and other infections are a big concern to students, parents, and school officials. We need to do all we can to prevent infection, and hand hygiene is the single strongest recommendation we're hearing. We're placing Crosstex waterless hand sanitizers in high-touch or high risk areas such as our sports field house, locker rooms, and cafeterias. Because it's fast and easy, we think the kids will use it, and we'll improve overall hand hygiene in the schools."
According to the CDC, when MRSA skin infections occur, cleaning and disinfection should be performed on surfaces that are likely to contact uncovered or poorly covered infections. Our Sanitex(R) line of surface disinfecting sprays and wipes are EPA listed as effective against MRSA.
Andrew G. Whitehead, Vice President of Sales and Marketing at Crosstex, added, "With all the different strains of bacteria and viruses out there, product claims against those bugs can be confusing. Crosstex's waterless hand sanitizers and surface disinfectants are listed by the EPA as effective against a number of bacteria and viruses, including MRSA. Those claims are clearly listed on the Crosstex website (http://www.crosstex.com)." He adds, "Crosstex products have held significant market share in healthcare markets for a number of years because of their high quality and efficacy. We are now introducing them into other markets, such as schools and businesses, as highly effective in meeting a growing public need."
Cantel Medical/Crosstex is offering free samples to school district superintendents, nurses and business administrators. For inquiries regarding products and services, please contact us at: MRSAhelp@cantelmedical.com or call Matt Conlon at 973-890-7220. For more MRSA information, please refer to the following websites:
About Crosstex International
A division of Cantel Medical Corp., Crosstex, founded in 1953, has its headquarters and major manufacturing operations in Hauppauge, New York. Sold throughout the world, Crosstex branded and private label products include patient towels and bibs, sterilization pouches and accessories, face masks, eyewear, disinfectants and deodorizers, germicidal wipes, hand care products, gloves, sponges, cotton products, needles and syringes, scalpels and blades, containers, saliva evacuators and ejectors. For further information, visit the Crosstex website at http://www.crosstex.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE: CMN) is a leading provider of infection prevention and control products in the healthcare market. Cantel's products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. Cantel also provides technical maintenance for its products and offers compliance training services for the transport of infectious and biological specimens. For further information, visit the Cantel website at http://www.cantelmedical.com.
Contact: R. Scott Jones Matt Conlon
President and CEO Vice President, Market Development
Cantel Medical Corp. Cantel Medical Corp.
Phone: (973) 890-7220 Phone: (973) 890-7220
|SOURCE Cantel Medical Corp.|
Copyright©2007 PR Newswire.
All rights reserved